BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19523139)

  • 21. Bimatoprost - a review.
    Patil AJ; Vajaranant TS; Edward DP
    Expert Opin Pharmacother; 2009 Nov; 10(16):2759-68. PubMed ID: 19874254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of eyebrow hypotrichosis using bimatoprost: a randomized, double-blind, vehicle-controlled pilot study.
    Beer KR; Julius H; Dunn M; Wilson F
    Dermatol Surg; 2013 Jul; 39(7):1079-87. PubMed ID: 23617229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eyelash preservation during chemotherapy and topical prostaglandin therapy.
    Moroi SE
    Arch Intern Med; 2010 Jul; 170(14):1269-70. PubMed ID: 20660849
    [No Abstract]   [Full Text] [Related]  

  • 24. Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata.
    Ochoa BE; Sah D; Wang G; Stamper R; Price VH
    J Am Acad Dermatol; 2009 Sep; 61(3):530-2. PubMed ID: 19700021
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of hypotrichosis of the eyelashes: focus on bimatoprost.
    Fagien S
    Plast Surg Nurs; 2015; 35(2):82-91. PubMed ID: 26020474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata.
    Roseborough I; Lee H; Chwalek J; Stamper RL; Price VH
    J Am Acad Dermatol; 2009 Apr; 60(4):705-6. PubMed ID: 19293023
    [No Abstract]   [Full Text] [Related]  

  • 27. Eyelash growth: a beneficial side effect of prostaglandin analogues.
    Bikowski J; Lau EG; Jacob SE
    Cutis; 2010 Apr; 85(4):187-8. PubMed ID: 20486457
    [No Abstract]   [Full Text] [Related]  

  • 28. Promising alternative clinical uses of prostaglandin F2α analogs: beyond the eyelashes.
    Choi YM; Diehl J; Levins PC
    J Am Acad Dermatol; 2015 Apr; 72(4):712-6. PubMed ID: 25601618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recovery of orbital fat pad prolapsus and deepening of the lid sulcus from topical bimatoprost therapy: 2 case reports and review of the literature.
    Aydin S; Işikligil I; Tekşen YA; Kir E
    Cutan Ocul Toxicol; 2010 Sep; 29(3):212-6. PubMed ID: 20670089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of an in vivo model for the study of eyelash biology and trichomegaly: mouse eyelash morphology, development, growth cycle, and anagen prolongation by bimatoprost.
    Tauchi M; Fuchs TA; Kellenberger AJ; Woodward DF; Paus R; Lütjen-Drecoll E
    Br J Dermatol; 2010 Jun; 162(6):1186-97. PubMed ID: 20346040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bimatoprost 0.03% versus brimonidine 0.2% in the prevention of intraocular pressure spike following neodymium:yttrium–aluminum–garnet laser posterior capsulotomy.
    Artunay O; Yuzbasioglu E; Unal M; Rasier R; Sengul A; Bahcecioglu H
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):513-7. PubMed ID: 20874499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lusher lashes, but at real risk.
    Consum Rep; 2010 Feb; 75(2):14. PubMed ID: 20361412
    [No Abstract]   [Full Text] [Related]  

  • 33. Adherence, persistence and cost-consequence comparison of bimatoprost topical ocular formulations.
    Alany RG
    Curr Med Res Opin; 2013 Sep; 29(9):1187-9. PubMed ID: 23829677
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term IOP lowering with bimatoprost in open-angle glaucoma patients poorly responsive to latanoprost.
    Sonty S; Donthamsetti V; Vangipuram G; Ahmad A
    J Ocul Pharmacol Ther; 2008 Oct; 24(5):517-20. PubMed ID: 18800869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bimatoprost for eyelash growth in Japanese subjects: two multicenter controlled studies.
    Harii K; Arase S; Tsuboi R; Weng E; Daniels S; VanDenburgh A
    Aesthetic Plast Surg; 2014 Apr; 38(2):451-60. PubMed ID: 24643895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eyelash growth induced by topical prostaglandin analogues, bimatoprost, tafluprost, travoprost, and latanoprost in rabbits.
    Giannico AT; Lima L; Russ HH; Montiani-Ferreira F
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):817-20. PubMed ID: 23981234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periorbital fat atrophy - an unfamiliar side effect of prostaglandin analogues.
    Jayaprakasam A; Ghazi-Nouri S
    Orbit; 2010 Dec; 29(6):357-9. PubMed ID: 21158579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iris heterochromia and unilateral eyelash hypertrichosis.
    Rao RC; Ballard TN; Chen TC
    JAMA; 2015 May; 313(19):1967-8. PubMed ID: 25988467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of topical alopecia and acne medications: notable stain enhancement by bimatoprost.
    Rashid RM
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1487-8. PubMed ID: 20384677
    [No Abstract]   [Full Text] [Related]  

  • 40. Topical bimatoprost for the treatment of eyebrow hypotrichosis.
    Schweiger ES; Pinchover L; Bernstein RM
    J Drugs Dermatol; 2012 Jan; 11(1):106-8. PubMed ID: 22206085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.